KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Exact Sciences (EXAS) over the last 11 years, with Q4 2025 value amounting to -$7.3 million.

  • Exact Sciences' Change in Receivables rose 5154.12% to -$7.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $48.9 million, marking a year-over-year increase of 568.97%. This contributed to the annual value of $48.9 million for FY2025, which is 568.97% up from last year.
  • According to the latest figures from Q4 2025, Exact Sciences' Change in Receivables is -$7.3 million, which was up 5154.12% from -$46.9 million recorded in Q3 2025.
  • Exact Sciences' 5-year Change in Receivables high stood at $73.0 million for Q2 2025, and its period low was -$46.9 million during Q3 2025.
  • Its 5-year average for Change in Receivables is $2.6 million, with a median of $1.6 million in 2022.
  • Its Change in Receivables has fluctuated over the past 5 years, first skyrocketed by 64376.88% in 2023, then tumbled by 930491.16% in 2025.
  • Quarter analysis of 5 years shows Exact Sciences' Change in Receivables stood at -$39.2 million in 2021, then rose by 15.48% to -$33.1 million in 2022, then surged by 109.39% to $3.1 million in 2023, then plummeted by 587.17% to -$15.2 million in 2024, then soared by 51.54% to -$7.3 million in 2025.
  • Its Change in Receivables was -$7.3 million in Q4 2025, compared to -$46.9 million in Q3 2025 and $73.0 million in Q2 2025.